Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-09-15 1:39 pm Purchase |
2023-09-08 | 13G | UroGen Pharma Ltd. URGN |
Great Point Partners, LLC | 2,620,545 8.510% |
2,620,545 (New Position) |
Filing History |
| 2023-06-16 1:31 pm Purchase |
2023-06-05 | 13G | Zura Bio Limited ZURA |
Great Point Partners, LLC | 3,295,000 7.650% |
3,295,000 (New Position) |
Filing History |
| 2023-04-13 1:58 pm Purchase |
2022-11-02 | 13G | Heron Therapeutics, Inc. HRTX |
Great Point Partners, LLC | 6,360,161 5.350% |
6,360,161 (New Position) |
Filing History |
| 2023-02-27 3:40 pm Purchase |
2023-02-17 | 13G | Precision BioSciences, Inc. DTIL |
Great Point Partners, LLC | 269,993 7.300% |
143,283 (+113.08%) |
Filing History |
| 2023-02-14 5:00 pm Unchanged |
2022-12-31 | 13G | OptiNose, Inc. OPTN |
Great Point Partners, LLC | 754,315 9.990% |
0 (Unchanged) |
Filing History |
| 2023-02-14 4:59 pm Sale |
2022-12-31 | 13G | KalVista Pharmaceuticals, Inc. KALV |
Great Point Partners, LLC | 1,055,801 3.100% |
-224,199 (-17.52%) |
Filing History |
| 2023-02-14 4:58 pm Sale |
2022-12-31 | 13G | 89bio, Inc. ETNB |
Great Point Partners, LLC | 700,000 1.370% |
-1,400,000 (-66.67%) |
Filing History |
| 2023-02-14 4:58 pm Sale |
2022-12-31 | 13G | Precision BioSciences, Inc. DTIL |
Great Point Partners, LLC | 126,710 3.430% |
-65,136 (-33.95%) |
Filing History |
| 2023-02-14 4:57 pm Purchase |
2022-12-31 | 13G | Alpine Immune Sciences, Inc. ALPN |
Great Point Partners, LLC | 3,637,718 7.920% |
189,197 (+5.49%) |
Filing History |
| 2023-02-13 4:10 pm Purchase |
2023-02-03 | 13G | Avalo Therapeutics, Inc. AVTX |
Great Point Partners, LLC | 4,061 7.120% |
4,061 (New Position) |
Filing History |
| 2022-12-01 4:03 pm Purchase |
2022-11-21 | 13G | OptiNose, Inc. OPTN |
Great Point Partners, LLC | 754,315 9.990% |
754,315 (New Position) |
Filing History |
| 2022-09-30 09:37 am Purchase |
2022-09-21 | 13G | Alpine Immune Sciences, Inc. ALPN |
Great Point Partners, LLC | 3,448,521 7.850% |
3,448,521 (New Position) |
Filing History |
| 2022-07-08 5:13 pm Purchase |
2022-06-29 | 13G | 89bio, Inc. ETNB |
Great Point Partners, LLC | 2,100,000 5.290% |
2,100,000 (New Position) |
Filing History |
| 2022-07-01 2:35 pm Purchase |
2022-06-22 | 13G | Precision BioSciences, Inc. DTIL |
Great Point Partners, LLC | 191,847 5.890% |
191,847 (New Position) |
Filing History |
| 2022-05-18 4:03 pm Purchase |
2022-05-09 | 13G | KalVista Pharmaceuticals, Inc. KALV |
Great Point Partners, LLC | 1,280,000 5.220% |
1,280,000 (New Position) |
Filing History |
| 2022-02-14 11:23 am Sale |
2021-12-31 | 13G | InflaRx N.V. IFRX |
Great Point Partners, LLC | 0 0.000% |
-4,400,000 (Position Closed) |
Filing History |
| 2021-03-08 4:10 pm Purchase |
2021-02-25 | 13G | InflaRx N.V. IFRX |
Great Point Partners, LLC | 4,400,000 9.690% |
4,400,000 (New Position) |
Filing History |
| 2021-02-16 4:13 pm Sale |
2020-12-31 | 13G | Abeona Therapeutics Inc. ABEO |
Great Point Partners, LLC | 0 0.000% |
-339,555 (Position Closed) |
Filing History |
| 2021-02-16 4:13 pm Sale |
2020-12-31 | 13G | Constellation Pharmaceuticals, Inc. CNST |
Great Point Partners, LLC | 1,024,800 2.150% |
-1,276,657 (-55.47%) |
Filing History |
| 2021-02-16 4:13 pm Sale |
2020-12-31 | 13G | Geron Corporation GERN |
Great Point Partners, LLC | 12,754,228 4.000% |
-10,342,889 (-44.78%) |
Filing History |